{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:33:04Z","timestamp":1768253584008,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,20]]},"DOI":"10.7759\/cureus.30529","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T05:51:07Z","timestamp":1666331467000},"source":"Crossref","is-referenced-by-count":3,"title":["Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Infertility Due to Premature Ovarian Failure"],"prefix":"10.7759","author":[{"given":"Kritika","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarju","family":"Zilate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1537-x","article-title":"Protective properties of heme oxygenase-1 expressed in umbilical cord mesenchymal stem cells help restore the ovarian function of premature ovarian failure mice through activating the JNK\/Bcl-2 signal pathway-regulated autophagy and upregulating the circulating of CD8+CD28- T cells","volume":"11","author":"Yin N","year":"2020","unstructured":"Yin N, Wu C, Qiu J, et al.. Protective properties of heme oxygenase-1 expressed in umbilical cord mesenchymal stem cells help restore the ovarian function of premature ovarian failure mice through activating the JNK\/Bcl-2 signal pathway-regulated autophagy and upregulating the circulating of CD8+CD28- T cells. Stem Cell Res Ther. 2020, 11:49. 10.1186\/s13287-019-1537-x","journal-title":"Stem Cell Res Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02529-w","article-title":"Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure","volume":"12","author":"Shareghi-Oskoue O","year":"2021","unstructured":"Shareghi-Oskoue O, Aghebati-Maleki L, Yousefi M. Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther. 2021, 12:454. 10.1186\/s13287-021-02529-w","journal-title":"Stem Cell Res Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2019.07.008","article-title":"Premature ovarian insufficiency and autoimmune diseases","volume":"60","author":"Domniz N","year":"2019","unstructured":"Domniz N, Meirow D. Premature ovarian insufficiency and autoimmune diseases. Best Pract Res Clin Obstet Gynaecol. 2019, 60:42-55. 10.1016\/j.bpobgyn.2019.07.008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(05)70051-7","article-title":"Premature ovarian failure","volume":"27","author":"Kalantaridou SN","year":"1998","unstructured":"Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinol Metab Clin North Am. 1998, 27:989-1006. 10.1016\/s0889-8529(05)70051-7","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)55915-9","article-title":"High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure","volume":"59","author":"Corenblum B","year":"1993","unstructured":"Corenblum B, Rowe T, Taylor PJ. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure.  Fertil Steril. 1993, 59:988-91. 10.1016\/s0015-0282(16)55915-9","journal-title":"Fertil Steril"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5114\/pm.2017.68592","article-title":"Premature ovarian failure","volume":"16","author":"Jankowska K","year":"2017","unstructured":"Jankowska K. Premature ovarian failure. Prz Menopauzalny. 2017, 16:51-6. 10.5114\/pm.2017.68592","journal-title":"Prz Menopauzalny"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7010007","article-title":"Umbilical cord blood mesenchymal stem cells as an infertility treatment for chemotherapy induced premature ovarian insufficiency","volume":"7","author":"Mohamed SA","year":"2019","unstructured":"Mohamed SA, Shalaby S, Brakta S, Elam L, Elsharoud A, Al-Hendy A. Umbilical cord blood mesenchymal stem cells as an infertility treatment for chemotherapy induced premature ovarian insufficiency. Biomedicines. 2019, 7:7. 10.3390\/biomedicines7010007","journal-title":"Biomedicines"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29004","article-title":"Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: a novel therapeutic paradigm","volume":"235","author":"Abbaszadeh H","year":"2020","unstructured":"Abbaszadeh H, Ghorbani F, Derakhshani M, Movassaghpour A, Yousefi M. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: a novel therapeutic paradigm. J Cell Physiol. 2020, 235:706-17. 10.1002\/jcp.29004","journal-title":"J Cell Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-010-9168-8","article-title":"Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord","volume":"7","author":"Fan CG","year":"2011","unstructured":"Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev Rep. 2011, 7:195-207. 10.1007\/s12015-010-9168-8","journal-title":"Stem Cell Rev Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2004.09.008","article-title":"Anti-M\u00fcllerian hormone and folliculogenesis","volume":"234","author":"Visser JA","year":"2005","unstructured":"Visser JA, Themmen AP. Anti-M\u00fcllerian hormone and folliculogenesis. Mol Cell Endocrinol. 2005, 234:81-6. 10.1016\/j.mce.2004.09.008","journal-title":"Mol Cell Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/13697130601135672","article-title":"Premature ovarian failure: a review","volume":"10","author":"Nippita TA","year":"2007","unstructured":"Nippita TA, Baber RJ. Premature ovarian failure: a review. Climacteric. 2007, 10:11-22. 10.1080\/13697130601135672","journal-title":"Climacteric"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/22027.8671","article-title":"Premature ovarian failure: an association with autoimmune diseases","volume":"10","author":"Ayesha","year":"2016","unstructured":"Ayesha, Jha V, Goswami D. Premature ovarian failure: an association with autoimmune diseases. J Clin Diagn Res. 2016, 10:QC10-2. 10.7860\/JCDR\/2016\/22027.8671","journal-title":"J Clin Diagn Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.03.056","article-title":"Current approaches for the treatment of premature ovarian failure with stem cell therapy","volume":"102","author":"Sheikhansari G","year":"2018","unstructured":"Sheikhansari G, Aghebati-Maleki L, Nouri M, Jadidi-Niaragh F, Yousefi M. Current approaches for the treatment of premature ovarian failure with stem cell therapy. Biomed Pharmacother. 2018, 102:254-62. 10.1016\/j.biopha.2018.03.056","journal-title":"Biomed Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1586\/17446651.4.2.173","article-title":"Premature ovarian failure: etiology and possible prevention","volume":"4","author":"Blumenfeld Z","year":"2009","unstructured":"Blumenfeld Z. Premature ovarian failure: etiology and possible prevention. Expert Rev Endocrinol Metab. 2009, 4:173-81. 10.1586\/17446651.4.2.173","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1815-4","article-title":"Genetic aspects of premature ovarian failure: a literature review","volume":"283","author":"Cordts EB","year":"2011","unstructured":"Cordts EB, Christofolini DM, Dos Santos AA, Bianco B, Barbosa CP. Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet. 2011, 283:635-43. 10.1007\/s00404-010-1815-4","journal-title":"Arch Gynecol Obstet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.09.014","article-title":"Clinical implications of the detection of Y-chromosome mosaicism in Turner's syndrome: report of 3 cases","volume":"90","author":"Bianco B","year":"2008","unstructured":"Bianco B, Nunes Lipay MV, Guedes AD, Verreschi IT. Clinical implications of the detection of Y-chromosome mosaicism in Turner's syndrome: report of 3 cases. Fertil Steril. 2008, 90:1197.e17-20. 10.1016\/j.fertnstert.2007.09.014","journal-title":"Fertil Steril"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/8.5.483","article-title":"Genetic disorders in premature ovarian failure","volume":"8","author":"Laml T","year":"2002","unstructured":"Laml T, Preyer O, Umek W, Hengstschlager M, Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update. 2002, 8:483-91. 10.1093\/humupd\/8.5.483","journal-title":"Hum Reprod Update"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1242\/dev.00969","article-title":"The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance","volume":"131","author":"Schmidt D","year":"2004","unstructured":"Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, Treier M. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development. 2004, 131:933-42. 10.1242\/dev.00969","journal-title":"Development"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2005.11.048","article-title":"LH receptor gene mutations and polymorphisms: an overview","volume":"260-2","author":"Piersma D","year":"2007","unstructured":"Piersma D, Verhoef-Post M, Berns EM, Themmen AP. LH receptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol. 2007, 260-2:282-6. 10.1016\/j.mce.2005.11.048","journal-title":"Mol Cell Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2004.05.002","article-title":"Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF)","volume":"222","author":"Sundblad V","year":"2004","unstructured":"Sundblad V, Chiauzzi VA, Escobar ME, Dain L, Charreau EH. Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol Cell Endocrinol. 2004, 222:53-9. 10.1016\/j.mce.2004.05.002","journal-title":"Mol Cell Endocrinol"},{"key":"ref21","article-title":"Premature ovarian failure: its relationship to autoimmune disease","volume":"66","author":"Alper MM","year":"1985","unstructured":"Alper MM, Garner PR. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol. 1985, 66:27-30.","journal-title":"Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052594","article-title":"Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge","volume":"22","author":"Szeliga A","year":"2021","unstructured":"Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al.. Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge. Int J Mol Sci. 2021, 22:2594. 10.3390\/ijms22052594","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000611","article-title":"Primary ovarian insufficiency: current concepts","volume":"110","author":"Collins G","year":"2017","unstructured":"Collins G, Patel B, Thakore S, Liu J. Primary ovarian insufficiency: current concepts. South Med J. 2017, 110:147-53. 10.14423\/SMJ.0000000000000611","journal-title":"South Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1258\/mi.2009.009020","article-title":"Aetiology of premature ovarian failure","volume":"15","author":"Vujovic S","year":"2009","unstructured":"Vujovic S. Aetiology of premature ovarian failure. Menopause Int. 2009, 15:72-5. 10.1258\/mi.2009.009020","journal-title":"Menopause Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03073.x","article-title":"Primary ovarian insufficiency: a more accurate term for premature ovarian failure","volume":"68","author":"Welt CK","year":"2008","unstructured":"Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008, 68:499-509. 10.1111\/j.1365-2265.2007.03073.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.309.6961.1034","article-title":"Pregnancy outcome and offspring after childhood cancer: data show no evidence of mutagenesis of the germ cells","volume":"309","author":"Hawkins MM","year":"1994","unstructured":"Hawkins MM. Pregnancy outcome and offspring after childhood cancer: data show no evidence of mutagenesis of the germ cells. BMJ. 1994, 309:1034.","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)53513-4","article-title":"Clinical features of young women with hypergonadotropic amenorrhea","volume":"53","author":"Rebar RW","year":"1990","unstructured":"Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril. 1990, 53:804-10. 10.1016\/s0015-0282(16)53513-4","journal-title":"Fertil Steril"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.18.1.0291","article-title":"Premature ovarian failure and ovarian autoimmunity","volume":"18","author":"Hoek A","year":"1997","unstructured":"Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 1997, 18:107-34. 10.1210\/edrv.18.1.0291","journal-title":"Endocr Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(98)00099-5","article-title":"Premature ovarian failure: an update","volume":"70","author":"Anasti JN","year":"1998","unstructured":"Anasti JN. Premature ovarian failure: an update. Fertil Steril. 1998, 70:1-15. 10.1016\/s0015-0282(98)00099-5","journal-title":"Fertil Steril"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-5-1325","article-title":"Combined 17 alpha-hydroxylase\/17,20-lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochrome P45017 alpha (CYP17) gene","volume":"70","author":"Yanase T","year":"1990","unstructured":"Yanase T, Sanders D, Shibata A, Matsui N, Simpson ER, Waterman MR. Combined 17 alpha-hydroxylase\/17,20-lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochrome P45017 alpha (CYP17) gene. J Clin Endocrinol Metab. 1990, 70:1325-9. 10.1210\/jcem-70-5-1325","journal-title":"J Clin Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)92562-4","article-title":"Relation between smoking and age of natural menopause: report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center","volume":"309","author":"Jick H","year":"1977","unstructured":"Jick H, Porter J, Morrison A. Relation between smoking and age of natural menopause: report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet. 1977, 309:1354-5. 10.1016\/s0140-6736(77)92562-4","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(78)90617-7","article-title":"Smoking and industrial pollution, and their effects on menopause and ovarian cancer","volume":"1","author":"Mattison DR","year":"1978","unstructured":"Mattison DR, Thorgeirsson SS. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet. 1978, 1:187-8. 10.1016\/s0140-6736(78)90617-7","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1016\/S0015-0282(16)49517-8","article-title":"Constituents of cigarette smoke inhibit human granulosa cell aromatase","volume":"46","author":"Barbieri RL","year":"1986","unstructured":"Barbieri RL, McShane PM, Ryan KJ. Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil Steril. 1986, 46:232-6.","journal-title":"Fertil Steril"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)53707-8","article-title":"Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization","volume":"54","author":"Scott RT Jr","year":"1990","unstructured":"Scott RT Jr, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril. 1990, 54:297-302. 10.1016\/s0015-0282(16)53707-8","journal-title":"Fertil Steril"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(95)00966-3","article-title":"Premature ovarian failure","volume":"23","author":"Davis SR","year":"1996","unstructured":"Davis SR. Premature ovarian failure. Maturitas. 1996, 23:1-8. 10.1016\/0378-5122(95)00966-3","journal-title":"Maturitas"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000206","article-title":"Update on primary ovarian insufficiency","volume":"22","author":"Hewlett M","year":"2015","unstructured":"Hewlett M, Mahalingaiah S. Update on primary ovarian insufficiency. Curr Opin Endocrinol Diabetes Obes. 2015, 22:483-9. 10.1097\/MED.0000000000000206","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0015","article-title":"Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy","volume":"89","author":"Kalantaridou SN","year":"2004","unstructured":"Kalantaridou SN, Naka KK, Papanikolaou E, et al.. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004, 89:3907-13. 10.1210\/jc.2004-0015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(97)81483-5","article-title":"Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failure","volume":"68","author":"Hartmann BW","year":"1997","unstructured":"Hartmann BW, Huber JC, Kirchengast S, S\u00f6regi, MD, Albrecht AE. Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failure. Fertil Steril. 1997, 68:103-7. 10.1016\/s0015-0282(97)81483-5","journal-title":"Fertil Steril"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee SJ","year":"2006","unstructured":"Lee SJ, Schover LR, Partridge AH, et al.. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006, 24:2917-31. 10.1200\/JCO.2006.06.5888","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger HG","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002, 77:3-5. 10.1016\/s0015-0282(02)02985-0","journal-title":"Fertil Steril"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.10.2129","article-title":"Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series","volume":"15","author":"Casson PR","year":"2000","unstructured":"Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod. 2000, 15:2129-32. 10.1093\/humrep\/15.10.2129","journal-title":"Hum Reprod"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmz065","article-title":"Immunomodulatory effect of human amniotic epithelial cells on restoration of ovarian function in mice with autoimmune ovarian disease","volume":"51","author":"Zhang Q","year":"2019","unstructured":"Zhang Q, Huang Y, Sun J, Gu T, Shao X, Lai D. Immunomodulatory effect of human amniotic epithelial cells on restoration of ovarian function in mice with autoimmune ovarian disease. Acta Biochim Biophys Sin (Shanghai). 2019, 51:845-55. 10.1093\/abbs\/gmz065","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(88)90791-0","article-title":"Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome)","volume":"158","author":"Cowchock FS","year":"1988","unstructured":"Cowchock FS, McCabe JL, Montgomery BB. Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol. 1988, 158:118-9. 10.1016\/0002-9378(88)90791-0","journal-title":"Am J Obstet Gynecol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0897.2002.01111.x","article-title":"Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and Th-1 versus Th-2 immune responses","volume":"48","author":"Gleicher N","year":"2002","unstructured":"Gleicher N. Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and Th-1 versus Th-2 immune responses. Am J Reprod Immunol. 2002, 48:252-4. 10.1034\/j.1600-0897.2002.01111.x","journal-title":"Am J Reprod Immunol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.5530\/ami.2016.1.7","article-title":"Autologous stem cells therapy, the first baby of idiopathic premature ovarian failure","volume":"3","author":"Edessy M","year":"2016","unstructured":"Edessy M, Hosni HN, Shady Y, Waf Y, Bakr S, Kamel M. Autologous stem cells therapy, the first baby of idiopathic premature ovarian failure. Acta Medica Int. 2016, 3:19. 10.5530\/ami.2016.1.7","journal-title":"Acta Medica Int"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X14666190314123006","article-title":"The roles of different stem cells in premature ovarian failure","volume":"15","author":"Zhang C","year":"2020","unstructured":"Zhang C. The roles of different stem cells in premature ovarian failure. Curr Stem Cell Res Ther. 2020, 15:473-81. 10.2174\/1574888X14666190314123006","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6539294","article-title":"Umbilical cord mesenchymal stem cell transplantation prevents chemotherapy-induced ovarian failure via the NGF\/TrkA pathway in rats","volume":"2019","author":"Zheng Q","year":"2019","unstructured":"Zheng Q, Fu X, Jiang J, et al.. Umbilical cord mesenchymal stem cell transplantation prevents chemotherapy-induced ovarian failure via the NGF\/TrkA pathway in rats. Biomed Res Int. 2019, 2019:6539294. 10.1155\/2019\/6539294","journal-title":"Biomed Res Int"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6901286","article-title":"Umbilical cord as prospective source for mesenchymal stem cell-based therapy","volume":"2016","author":"Arutyunyan I","year":"2016","unstructured":"Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T. Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells Int. 2016, 2016:6901286. 10.1155\/2016\/6901286","journal-title":"Stem Cells Int"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02212-0","article-title":"Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities","volume":"12","author":"Fu YX","year":"2021","unstructured":"Fu YX, Ji J, Shan F, Li J, Hu R. Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities. Stem Cell Res Ther. 2021, 12:161. 10.1186\/s13287-021-02212-0","journal-title":"Stem Cell Res Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3727\/096368915X686841","article-title":"Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy","volume":"24","author":"Ding DC","year":"2015","unstructured":"Ding DC, Chang YH, Shyu WC, Lin SZ. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015, 24:339-47. 10.3727\/096368915X686841","journal-title":"Cell Transplant"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2004-0013","article-title":"Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord","volume":"22","author":"Wang HS","year":"2004","unstructured":"Wang HS, Hung SC, Peng ST, et al.. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004, 22:1330-7. 10.1634\/stemcells.2004-0013","journal-title":"Stem Cells"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-012-9418-z","article-title":"The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord","volume":"9","author":"Bongso A","year":"2013","unstructured":"Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. Stem Cell Rev Rep. 2013, 9:226-40. 10.1007\/s12015-012-9418-z","journal-title":"Stem Cell Rev Rep"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.07.005","article-title":"Mesenchymal stem cells derived from Wharton jelly of the human umbilical cord ameliorate damage to human endometrial stromal cells","volume":"96","author":"Yang X","year":"2011","unstructured":"Yang X, Zhang M, Zhang Y, Li W, Yang B. Mesenchymal stem cells derived from Wharton jelly of the human umbilical cord ameliorate damage to human endometrial stromal cells. Fertil Steril. 2011, 96:1029-36. 10.1016\/j.fertnstert.2011.07.005","journal-title":"Fertil Steril"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-019-00337-4","article-title":"Transplantation of umbilical cord-derived mesenchymal stem cells on a collagen scaffold improves ovarian function in a premature ovarian failure model of mice","volume":"55","author":"Yang Y","year":"2019","unstructured":"Yang Y, Lei L, Wang S, et al.. Transplantation of umbilical cord-derived mesenchymal stem cells on a collagen scaffold improves ovarian function in a premature ovarian failure model of mice. In Vitro Cell Dev Biol Anim. 2019, 55:302-11. 10.1007\/s11626-019-00337-4","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2517514","article-title":"Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model","volume":"2016","author":"Song D","year":"2016","unstructured":"Song D, Zhong Y, Qian C, et al.. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. Biomed Res Int. 2016, 2016:2517514. 10.1155\/2016\/2517514","journal-title":"Biomed Res Int"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v6.i2.195","article-title":"Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility","volume":"6","author":"Nagamura-Inoue T","year":"2014","unstructured":"Nagamura-Inoue T, He H. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells. 2014, 6:195-202. 10.4252\/wjsc.v6.i2.195","journal-title":"World J Stem Cells"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEB.2013.0664","article-title":"Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?","volume":"20","author":"El Omar R","year":"2014","unstructured":"El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?. Tissue Eng Part B Rev. 2014, 20:523-44. 10.1089\/ten.TEB.2013.0664","journal-title":"Tissue Eng Part B Rev"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646948","article-title":"Application of stem cells to infertility treatment with emphasis on mesenchymal stem cells and ovarian stem cells","volume":"35","author":"Lorzadeh N","year":"2018","unstructured":"Lorzadeh N, Kazemirad N. Application of stem cells to infertility treatment with emphasis on mesenchymal stem cells and ovarian stem cells. Am J Perinatol. 2018, 35:1142-7. 10.1055\/s-0038-1646948","journal-title":"Am J Perinatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116609-umbilical-cord-derived-mesenchymal-stem-cells-for-the-treatment-of-infertility-due-to-premature-ovarian-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:13Z","timestamp":1707508333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116609-umbilical-cord-derived-mesenchymal-stem-cells-for-the-treatment-of-infertility-due-to-premature-ovarian-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":58,"URL":"https:\/\/doi.org\/10.7759\/cureus.30529","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}